↓ Skip to main content

CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent
11 patents

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
105 Mendeley
citeulike
1 CiteULike
Title
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
Published in
Cancer Immunology, Immunotherapy, April 2011
DOI 10.1007/s00262-011-1011-9
Pubmed ID
Authors

Jianda Yuan, Brian Ginsberg, David Page, Yanyun Li, Teresa Rasalan, Humilidad F. Gallardo, Yinyan Xu, Sylvia Adams, Nina Bhardwaj, Klaus Busam, Lloyd J. Old, James P. Allison, Achim Jungbluth, Jedd D. Wolchok

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Korea, Republic of 1 <1%
United Kingdom 1 <1%
Unknown 101 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 14%
Student > Ph. D. Student 14 13%
Other 12 11%
Student > Doctoral Student 9 9%
Student > Master 9 9%
Other 21 20%
Unknown 25 24%
Readers by discipline Count As %
Medicine and Dentistry 24 23%
Agricultural and Biological Sciences 21 20%
Biochemistry, Genetics and Molecular Biology 11 10%
Immunology and Microbiology 10 10%
Nursing and Health Professions 2 2%
Other 11 10%
Unknown 26 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2022.
All research outputs
#3,339,101
of 23,151,189 outputs
Outputs from Cancer Immunology, Immunotherapy
#226
of 2,903 outputs
Outputs of similar age
#15,523
of 109,934 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#1
of 18 outputs
Altmetric has tracked 23,151,189 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,903 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,934 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.